VR

Vikas Rambal

Active Director Director DIN 01759802
DIN 01759802 First appointment Dec 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Total affiliations 7 Since Dec 2015
Shareholding value •••• Premium profile

About Vikas Rambal

Data last updated:

Vikas Rambal is a Director at Perdaman Pharmaceuticals Private Limited (since 2015), Director at Sunrise International Labs Limited (since 2015) and Director at Perdaman Engineering And Consultancy Services Private Limited (since 2015), and holds 4 more current directorships. The companies operate in Pharma, Agriculture and Media and Publishing. The 6 current companies with reported revenue have a combined latest revenue of ₹54.02 Cr; the largest is Perdaman Pharmaceuticals Private Limited at ₹28.76 Cr (FY 2025).

DIN 01759802
Primary Designation Director
Industry Pharma
First Appointment 01 Dec 2015
Oldest Company Age 33 yrs
Largest company Perdaman Pharmaceuticals Private Limited · ₹28.76 Cr (FY 2025)
Combined revenue ₹54.02 Cr across 6 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Dec 20152008₹28.76 Cr (FY 2025)Active
Sunrise International Labs Limited U24239TG1993PLC015367
Director01 Dec 20151993₹21.39 Cr (FY 2024)Active
Director01 Dec 20152009₹2.55 Cr (FY 2024)Active
Director01 Dec 20152008₹68.8 Lakh (FY 2024)Active
Shirdi Bio Fuels Private Limited U01403DL2007PTC170200
Director01 Dec 20152007₹62.6 Lakh (FY 2020)Active
Director01 Dec 20152009₹30,734 (FY 2020)Active
Pkr Hospitality Private Limited U56100DL2026PTC463990
Director25 Feb 20262026Active

Directorship timeline

Open interactive timeline →
Perdaman Engineering And Consultancy Services Private Limited
Shirdi Bio Fuels Private Limited
Sunrise International Labs Limited
Perdaman Renewable Energy Private Limited
Premium access

Shareholding and investment profile for Vikas Rambal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Rambal

Vikas Rambal currently holds 7 directorships: Perdaman Pharmaceuticals Private Limited (Director, since 01 Dec 2015, revenue ₹28.76 Cr (FY 2025)); Sunrise International Labs Limited (Director, since 01 Dec 2015, revenue ₹21.39 Cr (FY 2024)); Perdaman Engineering And Consultancy Services Private Limited (Director, since 01 Dec 2015, revenue ₹2.55 Cr (FY 2024)); Perdaman Corporate Services Private Limited (Director, since 01 Dec 2015, revenue ₹68.8 Lakh (FY 2024)); Shirdi Bio Fuels Private Limited (Director, since 01 Dec 2015, revenue ₹62.6 Lakh (FY 2020)); and 2 more.

Vikas Rambal was first appointed on 01 Dec 2015 as Director at Perdaman Pharmaceuticals Private Limited. The most recent appointment on record is 25 Feb 2026 at Pkr Hospitality Private Limited.

The 6 current companies of Vikas Rambal that report revenue have a combined latest revenue of ₹54.02 Cr: Perdaman Pharmaceuticals Private Limited ₹28.76 Cr (FY 2025); Sunrise International Labs Limited ₹21.39 Cr (FY 2024); Perdaman Engineering And Consultancy Services Private Limited ₹2.55 Cr (FY 2024); Perdaman Corporate Services Private Limited ₹68.8 Lakh (FY 2024); Shirdi Bio Fuels Private Limited ₹62.6 Lakh (FY 2020); and 1 more.

The current boards of Vikas Rambal's companies include Dhruv Garg (Perdaman Pharmaceuticals Private Limited), Manoj Kumar Rambal (Perdaman Pharmaceuticals Private Limited), Samir Madhukar Garud (Perdaman Pharmaceuticals Private Limited), Sarojni Rambal (Perdaman Pharmaceuticals Private Limited), Shubham Kumar Namdev (Perdaman Pharmaceuticals Private Limited), Usha Rambal (Perdaman Pharmaceuticals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available